Exactly. They should be able to take whatever experimental drugs might be available. The problem is, how do companies identify these patients or how do patient

Exactly. They should be able to take whatever experimental drugs might be available. The problem is, how do companies identify these patients or how do patients identify these companies without leaving room for massive abuse. Maybe the treatments have to be zero cost? That feels like it would eliminate all bad actors?